4-[[6-cyano-7-(1-methoxypropan-2-yl)pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-cyclopropyloxybenzoic acid
C21H21N5O4 — CID 175544053
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[[6-cyano-7-(1-methoxypropan-2-yl)pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-cyclopropyloxybenzoic acid
4-[[6-cyano-7-(1-methoxypropan-2-yl)pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-cyclopropyloxybenzoic acid (PubChem CID 175544053) has the molecular formula C21H21N5O4 and a molecular weight of 407.43 g/mol. Its IUPAC name is 4-[[6-cyano-7-(1-methoxypropan-2-yl)pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-cyclopropyloxybenzoic acid.
Molecular Properties
| Compound Name | 4-[[6-cyano-7-(1-methoxypropan-2-yl)pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-cyclopropyloxybenzoic acid |
|---|---|
| PubChem CID | 175544053 |
| Molecular Formula | C21H21N5O4 |
| Molecular Weight | 407.43 g/mol |
| Exact Mass | 407.16 |
| IUPAC Name | 4-[[6-cyano-7-(1-methoxypropan-2-yl)pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-cyclopropyloxybenzoic acid |
| SMILES | COCC(C)n1c(C#N)cc2cnc(Nc3ccc(C(=O)O)cc3OC3CC3)nc21 |
| InChI | InChI=1S/C21H21N5O4/c1-12(11-29-2)26-15(9-22)7-14-10-23-21(25-19(14)26)24-17-6-3-13(20(27)28)8-18(17)30-16-4-5-16/h3,6-8,10,12,16H,4-5,11H2,1-2H3,(H,27,28)(H,23,24,25) |
| InChIKey | LSHMGOJPUNSCJW-UHFFFAOYSA-N |
| XLogP | 3.49 |
| TPSA | 122.29 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 407.43 |
| LogP ≤ 5 | 3.49 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175544053 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.